A university in Abu Dhabi is lending its resources to companies in order to help them produce medical items.
According to national news agency WAM, Mubadala Healthcare is utilising NYU Abu Dhabi’s (NYUAD) 3D printers and Core Technology Platforms to meet the growing demand for critical healthcare supplies.
Mubadala’s campaign aims to meet the needs of medical staff, amid the COVID-19 pandemic, in a sustainable way.
They will be producing 3D printed masks, similar to the N95 face mask, that are reusable and have replacement filters.
Medical experts at Cleveland Clinic Abu Dhabi will be testing the equipment and offering their professional feedback, should there be any adjustments to be made to the medical products.
The teams producing the supplies will be turning around physical prototypes in less than 48 hours.


H.H. Sheikh Mohammed issues law defining Dubai Municipality's mandate
Sharjah reopens beaches to the public after oil spill
UAE President meets US delegation following trilateral talks with Ukraine, Russia
Abu Dhabi arrests man in AED 14 million gold jewellery fraud
Several dead and injured in Fujairah road collision
Ras Al Khaimah Ruler attends COP31 Leaders’ Summit
H.H. Sheikh Hamdan honours winners of inaugural Dubai-it Award
Ras Al Khaimah reopens several beaches to the public
Abu Dhabi expands EV charging points in public parking areas
Dubai student card unlocks public transport savings, global discounts
H.H. Sheikh Theyab inaugurates ICMM World Congress of Military Medicine
UAE lifts visa restrictions on Ugandan nationals
Dr Gargash highlights UAE's 'constructive role' in Russia-Ukraine-US trilateral talks
Ras Al Khaimah Ruler leads UAE delegation at COP31
Dubai to reward residents with AED 2,500 for naming community parks
ADNOC L&S vessel sustains damage following attack
H.H. Sheikh Khaled, H.H. Sheikh Hamdan discuss key national priorities
Sheikh Abdullah attends third round of Russia-Ukraine-US trilateral talks
UAE completes critical design review of 'Sirb-1' satellite
UAE conditionally approves new use of Ultomiris for kidney disease patients
